+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

European Cardiology Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Europe
  • Orion Market Research Private Limited
  • ID: 4901016
UP TO OFF until Dec 31st 2022
European Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025.

The European cardiology market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The market is mainly driven owing to the well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and others. The major factor contributing to the European cardiology market is the rising prevalence of CVDs. Unhealthy lifestyle such as smoking, consumption of drugs and alcohol in European countries are the major factors for increasing CVD incidences among men and women. Government initiatives, programs and funding related to increasing awareness toward CVD are also contributing to the growth of the market in the region.

The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.

The companies which are contributing to the growth of the European market include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, General Electric Co., Medtronic PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology

The market study of the European cardiology market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device companies, pharmaceuticals companies, research institutes, hospitals, and government organizations for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. European Cardiology Market Research and Analysis by Device Type
2. European Cardiology Market Research and Analysis by Drug Type
3. European Cardiology Market Research and Analysis by Mechanism
4. European Cardiology Market Research and Analysis by Surgeries Type

The Report Covers:
  • Comprehensive research methodology of the European cardiology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the European cardiology market.
  • Insights about market determinants which are stimulating the European cardiology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Cardiology Market by Device Type
5.1.1. Angioplasty
5.1.2. Cardiovascular stents
5.1.3. Cardiovascular catheters
5.1.4. Cardiac rhythm management
5.1.5. Cardiovascular assistive devices
5.2. European Cardiology Market by Drug Type
5.2.1. Antithrombotic drugs
5.2.2. Antidyslipidemic drugs
5.2.3. Antihypertensive drugs
5.2.4. Anti-stroke drugs
5.3. European Cardiology Market by Mechanism
5.3.1. Beta blockers
5.3.2. Beta agonists
5.3.3. Alpha blockers
5.3.4. Alpha agonists
5.3.5. Sodium channel blockers
5.3.6. Calcium channel blockers
5.3.7. Vasodilators
5.3.8. Renin inhibitors
5.3.9. Angiotensin receptor blockers
5.3.10. Diuretics
5.3.11. Thrombolytics
5.4. European Cardiology Market by Surgeries Type
5.4.1. Coronary artery bypass grafting
5.4.2. Transmyocardial laser revascularization
5.4.3. Heart valve repair
5.4.4. Arrhythmia treatment
5.4.5. Aneurysm repair
5.4.6. Heart transplant
6. Regional Analysis
6.1. UK
6.2. Germany
6.3. Italy
6.4. France
6.5. Spain
6.6. Rest of Europe
7. Company Profiles
7.1. Abbott Laboratories
7.2. AstraZeneca PLC
7.3. Bayer AG
7.4. Boehringer Ingelheim International GmbH
7.5. F. Hoffmann-La Roche AG
7.6. General Electric Co.
7.7. Medtronic PLC
7.8. Merck KGaA
7.9. Novartis International AG
7.10. Sanofi S.A.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche AG
  • General Electric Co.
  • Medtronic PLC
  • Merck KGaA
  • Novartis International AG
  • Sanofi S.A.